Bessemer Group Inc Biotechnology

Bessemer Group Inc

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
RXRX Recursion Pharmaceuticals, Inc.	$1.35B	$1,000 0.0% of portfolio	185	Q3 2024 New
RGNX Regenxbio Inc.	$355M	$1,000 0.0% of portfolio	95	Q3 2024 New
REPL Replimune Group, Inc.	$687M	$1,000 0.0% of portfolio	120	Q3 2024 New
RVNC Revance Therapeutics, Inc.	$212M	$1,000 0.0% of portfolio	165	Q3 2024 New
ROIV Roivant Sciences Ltd.	$7.67B	$1,000 0.0% of portfolio	110	Q3 2024 New
SRRK Scholar Rock Holding Corp	$2.09B	$1,000 0.0% of portfolio	130	Q3 2024 New
SNDX Syndax Pharmaceuticals Inc	$878M	$1,000 0.0% of portfolio	65	Q3 2024 New
URGN Uro Gen Pharma Ltd.	$242M	$1,000 0.0% of portfolio	85	Q3 2024 New
VTYX Ventyx Biosciences, Inc.	$97.8M	$1,000 0.0% of portfolio	520	Q3 2024 New
VIR Vir Biotechnology, Inc.	$1.31B	$1,000 0.0% of portfolio	140	Q3 2024 New
FDMT 4 D Molecular Therapeutics, Inc.	$214M	$0 0.0% of portfolio	20	Q3 2024 New
ARDX Ardelyx, Inc.	$863M	$0 0.0% of portfolio	15	Q3 2024 New
IBRX Immunity Bio, Inc.	$1.35B	$0 0.0% of portfolio	50	Q2 2024 New
NAUT Nautilus Biotechnology, Inc.	$202M	$0 0.0% of portfolio	140	Q3 2024 New
STOK Stoke Therapeutics, Inc.	$447M	$0 0.0% of portfolio	15	Q3 2024 New
TNYA Tenaya Therapeutics, Inc.	$41.4M	$0 0.0% of portfolio	150	Q3 2024 New

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

Stay updated on Bessemer Group Inc with notifications on news.